102 related articles for article (PubMed ID: 16159096)
1. Recurrent artery-to-artery embolism during intravenous t-PA therapy for acute ischemic stroke.
Anderson CD; Bergman DL; Bernstein RA
Neurocrit Care; 2005; 3(1):54-6. PubMed ID: 16159096
[TBL] [Abstract][Full Text] [Related]
2. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke.
Tanaka K; Ohara T; Ishigami A; Ikeda Y; Matsushige T; Satow T; Ishibashi-Ueda H; Iihara K; Toyoda K
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):395-7. PubMed ID: 23545321
[TBL] [Abstract][Full Text] [Related]
3. Recurrent embolization during intravenous administration of tissue plasminogen activator in acute cardioembolic stroke. A case report.
Yasaka M; Yamaguchi T; Yonehara T; Moriyasu H
Angiology; 1994 Jun; 45(6):481-4. PubMed ID: 8203776
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes after intravenous fibrinolysis in cryptogenic strokes with or without patent foramen ovale.
Chang JJ; Chiem T; Alderazi YJ; Chapple K; Restrepo L
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e492-9. PubMed ID: 23871701
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic therapy in acute ischemic stroke patients with cardiac thrombus.
Derex L; Nighoghossian N; Perinetti M; Honnorat J; Trouillas P
Neurology; 2001 Dec; 57(11):2122-5. PubMed ID: 11739840
[TBL] [Abstract][Full Text] [Related]
6. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
[TBL] [Abstract][Full Text] [Related]
7. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
8. Pre-existing Mobile Cardiac Thrombus and the Risk of Early Recurrent Embolism after Intravenous Thrombolysis: A Case Report.
Kobayashi M; Tanaka R; Yamashiro K; Ueno Y; Kato E; Miura S; Daida H; Hattori N
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):e161-3. PubMed ID: 25836630
[TBL] [Abstract][Full Text] [Related]
9. [Intravenous thrombolysis for acute ischemic stroke: past, present and future].
Hayakawa M
Rinsho Shinkeigaku; 2014; 54(12):1197-9. PubMed ID: 25672743
[TBL] [Abstract][Full Text] [Related]
10. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
[TBL] [Abstract][Full Text] [Related]
11. Myocardial infarction following t-PA for acute stroke.
Mehdiratta M; Murphy C; Al-Harthi A; Teal PA
Can J Neurol Sci; 2007 Nov; 34(4):417-20. PubMed ID: 18062448
[TBL] [Abstract][Full Text] [Related]
12. Relative CBV ratio on perfusion-weighted MRI indicates the probability of early recanalization after IV t-PA administration for acute ischemic stroke.
Sohn SW; Park HS; Cha JK; Kim DH; Kang MJ; Choi JH; Nah HW; Huh JT
J Neurointerv Surg; 2016 Mar; 8(3):235-9. PubMed ID: 25583534
[TBL] [Abstract][Full Text] [Related]
13. Early embolic events complicating intravenous thrombolysis for acute ischemic stroke.
Chou PS; Lin CH; Chao HL; Chao AC
Am J Emerg Med; 2012 Nov; 30(9):2079.e3-5. PubMed ID: 22205004
[TBL] [Abstract][Full Text] [Related]
14. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
[TBL] [Abstract][Full Text] [Related]
15. A Myocardial Infarction During Intravenous Recombinant Tissue Plasminogen Activator Infusion for Evolving Ischemic Stroke.
Fitzek S; Fitzek C
Neurologist; 2015 Sep; 20(3):46-7. PubMed ID: 26375375
[TBL] [Abstract][Full Text] [Related]
16. Stroke and cardiac papillary fibroelastoma: mechanical thrombectomy after thrombolytic therapy.
Santos AF; Pinho J; Ramos V; Pardal J; Rocha J; Ferreira C
J Stroke Cerebrovasc Dis; 2014; 23(5):1262-4. PubMed ID: 24144594
[TBL] [Abstract][Full Text] [Related]
17. Intravenous tissue plasminogen activator before endovascular treatment increases symptomatic intracranial hemorrhage in patients with occlusion of the middle cerebral artery second division: subanalysis of the RESCUE-Japan Registry.
Takagi T; Yoshimura S; Uchida K; Enomoto Y; Egashira Y; Yamagami H; Sakai N;
Neuroradiology; 2016 Feb; 58(2):147-53. PubMed ID: 26494464
[TBL] [Abstract][Full Text] [Related]
18. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.
Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666
[TBL] [Abstract][Full Text] [Related]
19. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion.
Yalcin-Cakmakli G; Akpinar E; Topcuoglu MA; Dalkara T
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):74-7. PubMed ID: 19110150
[TBL] [Abstract][Full Text] [Related]
20. Sequential combination of two intravenous thrombolytics (recombinant tissue plasminogen activator/tenecteplase) in a patient with stroke and cardioembolic basilar artery occlusion.
Smadja D; Olindo S; Saint-Vil M; Chausson N
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):68-71. PubMed ID: 19110148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
